two new pending drugs for diabetes, Pargluva (muraglitazar) and Exubera (inhaled insulin)

You'll hear about two new pending drugs for diabetes, Pargluva (muraglitazar) and Exubera (inhaled insulin).

Pargluva will be first in a new class of oral drugs...called glitazars.

Glitazars are called "two-in-one" drugs. They improve blood glucose like a glitazone AND improve lipids like a fibrate.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote